Ana Aparicio, Rebecca Slack Tidwell, Sreyashi Basu, Zhong He, Amado J. Zurita, Bilal Ahmed Siddiqui, Sumit Kumar Subudhi, Paul Gettys Corn, Craig A. Kovitz, Bagi Jana, Andrew Warren Hahn, Omar Alhalabi, Rahul Sheth, Jessica Deinert, Christopher Logothetis, Rama Soundararajan, Timothy C. Thompson, Padmanee Sharma, Patrick Glen Pilié. "C3NIRA: Randomized phase II study of carboplatin-cabazitaxel-cetrelimab (anti-PD-1) induction followed by niraparib +/- cetrelimab maintenance in men with aggressive variant prostate cancers (AVPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5008